Free tool
Oncology stocks
We cover 8 companies grouped under the Oncology theme. The median market value in the group is $85.80M. Across the group, the median move over the past trading day is +0.61%. Price change over the past year runs from −57.4% to +51.4% across the middle 80 percent of the group, with a median of −19.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0J9P.L | Incyte Corporation | $21.10B | Large cap | +53.49% | Oct 27, 2026 |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% | Nov 5, 2026 |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +50.53% | Oct 27, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% | Sep 28, 2026 |
| 0J4V.L | Heron Therapeutics, Inc. | $82.85M | Micro cap | −78.12% | Nov 3, 2026 |
| 0RAD.L | OSE Immunotherapeutics SA | $51.87M | Micro cap | −48.50% | Sep 28, 2026 |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% | Nov 25, 2026 |
| 0GP7.L | Medivir AB (publ) | $5.78M | Micro cap | +1.60% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.